Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug research, development and life-cycle decisions.
Our Communications
Latest news from Pharmetheus.
June 23, 2022
Pharmetheus at Page in Ljubljana, 2022
June 21, 2022
New overview articles related to subcutaneous administration
June 14, 2022
Introduction to new Board member Tomas Salmonson
June 8, 2022
Welcome Joakim Hellner!
May 31, 2022
Open Ph.D. Position
May 25, 2022
Workshops at Page 2022
May 24, 2022
Welcome Anna Mc Laughlin!
May 18, 2022
Population PK analysis supporting accelerated regulatory approvals for tepotinib in metastatic non-small cell lung cancer
May 17, 2022
Introduction to new Board member Birgit Köster Hoffman
May 10, 2022
Anti-drug antibody news
June 23, 2022What is the immunogenic profile of a drug and what to do about it? At Pharmetheus, we have, together with the whole team, reviewed with interest the new draft FDA guidance.
On the QSP side, we are progressing with our contributions to the subcutaneous delivery platform, upon which Erik Sjögren will present at PAGE: A platform for mechanistic modelling of subcutaneous administration with the effect of immunogenicity within the Open Systems Pharmacology framework
When it comes to PKPD models, we are following the collaborative advances in Hidden Markov Modeling, with contributions by Elodie Plan:
Services
Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.
Our team
Request our services
If you are interested in our services, please fill out the form below.
How we work
Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.
Contact
About
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..